Endocrinology Flashcards
Pathophysiology of T1DM
autoimmune destruction of β-cells → absolute
insulin deficiency.
Pathophysiology of T2DM
insulin resistance and β-cell dysfunction → relative insulin deficiency
Presenting symptoms of diabetes mellitus
polyuria, polydipsia, ↓wt, lethargy
- T1DM - DKA
Diagnosis of DM
Symptoms and 1 abnormal result
Fasting ≥7mM
Random ≥11.1mM
HbA1c ≥ 6.5% (T2DM)
Or 2 results at different times
Secondary causes of DM
Drugs: steroids, anti-HIV, atypical neuroletics, thiazides
Pancreatic: CF, chronic pancreatitis, HH, pancreatic Ca
Endo: Phaeo, Cushings, Acromegaly, T4
Other: glycogen storage diseases
Define Metabolic Syndrome
Central obesity (↑ waist circumference) and two of: ↑ Triglycerides
↓ HDL
HTN
Hyperglycaemia: DM, IGT, IFG
Lifestyle Modifications in DM
Diet - healthy, reduced refined CHO, avoid alcohol Exercise Lipids (T2 - >40 - statin) ABP - <130/80 Aspirin >50y/o Yearly/6m check up - control, complications, competency, coping Smoking cessation
Examination for DM complications
Macro Pulses BP Cardiac auscultation Micro Fundoscopy ACR + U+Es Sensory testing plus foot inspection
Medical management of T2DM
1) Metformin
2) + sulphonylura/Gliptin/ Pioglitazone
3) + another
4) + insulin
Metformin - action, SE and CI
↑ cells sensitivity to insulin
SE - diarrhoea, abdo pain, vitamin b12 deficiency, lactic acidosis
CI - GFR<30, tissue hypoxia (sepsis, MI)
Sulphonylureas - example action and SE
Gliclazide
↑ insulin release from β-cells
SE - weight gain, GI disturbances, ↑ risk hypoglycaemia
Pioglitazone - Action and SE
binding PPAR- γ- upregulates genes that affect glucose and lipid metabolism
SE - weight gain, oedema, liver dysfunction, effects on bone metabolism
Gliptins - example, action and SE
Sitagliptin - protect native GLP-1 from inactivation by DPP-4
SE - GI
Sodium – Glucose Co-transporter 2 inhibitors - example, action and SE
Dapagliflozin - Inhibit SGLT2 (PT) in kidney- decrease glucose reabsorption.
SE - weight loss, Low risk of hypoglycaemia, polyuria and lower UTIs/ Thrush/Urosepsis
Common Insulin Regimes
Biphasic - Twice daily pre-mixed
- Mixed intermediate and rapid acting insulin BD - before breakfast and dinner
- regular lifestyle: children, older pts.
Basal-Bolus Regime
- Bedtime long-acting + short acting before each meal
- allowing flexible lifestyle
Insulin requirements when ill
Insulin requirements usually ↑ (even if food intake ↓)
Maintain calories (e.g. milk)
Check BMs ≥4hrly and test for ketonuria
↑ insulin dose if glucose rising
if in hospital and NBM - variable rate insulin infusion (check capillary blood glucose every 1-2 hours)
- stop when eating and drinking and and long acting insulin
SE of Insulin
Hypoglycaemia
- At risk: EtOH binge, β-B (mask symptoms), elderly
Lipohypertrophy
- Rotate injection site: abdomen, thighs
Wt. gain in T2DM
Macrovascular DM complications and Rx
MI: May be “silent” due to autonomic neuropathy
PVD: claudication, foot ulcers
CVA
Rx: Manage CV risk factors BP (aim <130/80) Smoking Lipids HBA1c <6% - regular fundoscopy, foot check
Features of diabetic feet
ISCHAEMIA Critical toes Absent pulses (do ABPI) Ulcers: painful, punched-out, foot margins, pressure points
NEUROPATHY
Loss of protective sensation
Deformity: Charcot’s joints, pes cavus, claw toes
Injury or infection over pressure points
Ulcers: painless, punched-out, metatarsal heads, calcaneum
Management of diabetic feet
Conservative
Daily foot inspection (e.g. ̄c mirror)
Comfortable / therapeutic shoes
Regular chiropody (remove callus)
Medical
Rx infection: benpen + fluclox ± metronidazole
Surgical Abscess or deep infection Spreading cellulitis Gangrene Suppurative arthritis
Pathophysiology of nephropathy in DM
Hyperglycaemia → nephron loss and glomerulosclerosis
Features of nephropathy in DM
Microalbuminuria: urine albumin:Cr (ACR) ≥30mg/mM
If present → ACEi / ARA
Refer if UCR >70
Pathogenesis of retinopathy in DM
Microvascular disease → retinal ischaemia → ↑VEGF
↑ VEGF → new vessel formation
Presentation of retinopathy of DM
Retinopathy and maculopathy
Cataracts
Rubeosis iris: new vessels on iris → glaucoma
CN palsies
Stages of Diabetic retinopathy
Background Retinopathy
Dots: microaneurysms
Blot haemorrhages
Hard exudates: yellow lipid patches
Pre-proliferative Retinopathy
Cotton-wool spots (retinal infarcts)
Venous beading
Haemorrhages
Proliferative Retinopathy
New vessels
Pre-retinal or vitreous haemorrhage
Maculopathy
↓ acuity may be only sign
Hard exudates w/i one disc width of macula
Pathophysiology of neuropathy
Metabolic: glycosylation, ROS, sorbitol accumulation
Ischaemia: loss of vasa nervorum
Features of polyneuropathy in DM
Glove and stocking: length-dependent ( feet 1st)
Loss of all modalities
Absent ankle jerks
Numbness, tingling, pain (worse @ night)
Treatment of polyneuropathy of DM
Paracetamol
Amitriptyline, Gabapentin, SSRI
Capsaicin cream
Baclofen
Pathogenesis of DKA
Ketogenesis
↓ insulin → ↑ stress hormones and ↑ glucagon
→ ↓ glucose utilisation + ↑ fat β-oxidation
↑ fatty acids → ↑ ATP + generation of ketone bodies.
Dehydration
↓ insulin → ↓ glucose utilisation + ↑ gluconeogenesis → severe hyperglycaemia
→ osmotic diuresis → dehydration
Also, ↑ ketones → vomiting
Acidosis
Dehydration → renal perfusion
Hyperkalaemia
Precipitants of DKA
Infection / stress ± stopping insulin
New T1DM
Alcohol
Presentation of DKA
Abdo pain + vomiting Gradual drowsiness/ confusion Sighing “Kussmaul” hyperventilation Dehydration Ketotic breath
Diagnosis of DKA
Acidosis (↑AG): pH <7.3 (± HCO3 <15mM)
Hyperglycaemia: ≥11.1mM (or known DM)
Ketonaemia: ≥3mM (≥2+ on dipstix)
Investigations for DKA
Urine: ketones and glucose, MCS Cap glucose and ketones VBG: acidosis + ↑K Bloods: U+E, FBC, glucose, cultures CXR: evidence of infection
Treatment of DKA
- Fluids
- Potassium replacement (if <5.5)
- Insulin Infusion (actrapid) - 1 unit/kg/hr
+- catheter; NGT; LMWH; find and treat precipitating factors
Aims with DKA treatment
↓ ketones by ≥0.5mM/h or ↑HCO3 by ≥3mM/h
↓ plasma glucose by ≥3mM/h
Maintain K in normal range
Avoid hypoglycaemia
Resolution of DKA
Ketones <0.3mM + venous pH>7.3 (HCO3 >18mM)
Transfer to sliding scale if not eating
Transfer to SC insulin when eating and drinking
Pt Education and action plan
Hyperglycaemic Hyperosmolar State presentation
Usually T2DM, often new presentation Usually older Long hx (e.g. 1wk) Marked dehydration and glucose >30mM/L No acidosis (no ketogenesis) Osmolality >320mosmol/kg
Complications of HHS
Occlusive events are common: DVT, stroke, leg ischaemia
- Give LMWH
Management of HHS
Rehydrate --> 0.9% NS over 48h - May need ~9L Wait 1h before starting insulin - It may not be needed - Start low to avoid rapid changes in osmolality --> E.g. 1-3u/hr (to avoid cerebral oedema) Look for precipitant - MI - Infection - Bowel infarct
Symptoms of hypoglycaemia
Autonomic: 2.5-3 Sweating Anxiety Hunger Tremor Palpitations
Neuroglycopenic: <2.5 Confusion Drowsiness Seizures Personality change Focal neurology (e.g. CN3) Coma (<2.2)